An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2013-08-08
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 141
- Registration Number
- NCT01006356
Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1121
- Registration Number
- NCT01005628
An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
Phase 4
Completed
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2014-03-11
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 75
- Registration Number
- NCT00992407
Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 132
- Registration Number
- NCT00871728
Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1576
- Registration Number
- NCT00797017
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 289
- Registration Number
- NCT00784238
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
- First Posted Date
- 2008-10-06
- Last Posted Date
- 2013-10-23
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 190
- Registration Number
- NCT00766831
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 190
- Registration Number
- NCT00761579
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2014-03-05
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 491
- Registration Number
- NCT00761189
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 387
- Registration Number
- NCT00761605
© Copyright 2025. All Rights Reserved by MedPath